Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 183.80
-3.00 (-1.61%)
Aug 15, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.79 billion as of August 15, 2025. Its market cap has decreased by -64.03% in one year.
Market Cap
5.79B
Enterprise Value
5.58B
Revenue
822.93M
Ranking
n/a
PE Ratio
52.56
Stock Price
183.80
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.79B, an increase of 1,457.63%. That is a compound annual growth rate of 23.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 93.73B |
| Sectra AB | 66.63B |
| Getinge AB | 54.96B |
| Medicover AB | 41.37B |
| Camurus AB | 38.68B |
| Asker Healthcare Group AB | 38.05B |
| BioArctic AB | 21.07B |
| AddLife AB | 20.16B |